Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedA newer revision entry, v3.6.2, was added to the study record history, replacing the previous v3.6.0. This signals an update to the record version.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study record history was updated to include the responsible party (Shen Lin) and a last-verified marker, and the revision was advanced to v3.6.0, replacing the previous status block and version.SummaryDifference3%

- Check24 days agoChange DetectedThe history shows a new revision label, updating from v3.5.4 to v3.5.5. This appears to be an internal update to the record page rather than new study information.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry 'Revision: v3.5.4' was added to the record history, replacing the earlier 'Revision: v3.5.3'. This indicates a new version of the page has been published in the history.SummaryDifference0.1%

- Check66 days agoChange DetectedThis update reflects a minor website/app revision change for ClinicalTrials.gov (version number increment), with no new or removed information in the trial’s record history table.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.